Which clotting drug is safer for trauma patients? new study aims to find out

NCT ID NCT07290634

First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 19 times

Summary

This study looks at trauma patients who need large blood transfusions and compares two drugs (PCC and rFVIIa) that help stop bleeding. The main goal is to see which drug causes fewer dangerous blood clots. Researchers will also track deaths, hospital stays, and other complications. The study is small, with only 4 participants planned, so results will be very early and not conclusive.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UF Health Jacksonville (Shands Hospital)

    RECRUITING

    Jacksonville, Florida, 32209, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UF Health Jacksonville (Shands Hospital)

    RECRUITING

    Jacksonville, Florida, 32218, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.